The Benefits of Telephone Follow-up (TFU)

Sponsor

Brandon University (Other)

Overall Status

Recruiting

CT.gov ID

NCT04793282

Collaborator

(none)

Enrollment

Location

Arms

Anticipated Duration (Months)

6.3

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study will investigate the impact of a brief telephone follow-up following a mental health assessment in the emergency department. The purpose of the telephone call will be to provide psycho-education, clarify any questions and reinforce discharge planning.

Condition or Disease	Intervention/Treatment	Phase
Mental Health Issue	Behavioral: Telephone Follow-up	N/A

Detailed Description

This is a randomized controlled trial. The experimental group will receive a phone call within 72 hours of discharge to provide psycho education, clarify any questions they may have and to reinforce discharge plans made in the ED. The control group will not receive this phone call. Within 30 days of discharge, both groups will receive a phone call to collect data on treatment compliance including medication and follow-up adherence and if any additional visits to the Emergency Department were necessary.

Study Design

Study Type:

Interventional

Anticipated Enrollment :

75 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

Single (Participant)

Primary Purpose:

Supportive Care

Official Title:

The Benefits of Telephone Follow-Up After a Mental Health Assessment in an Emergency Department

Actual Study Start Date :

Aug 2, 2022

Anticipated Primary Completion Date :

Aug 1, 2023

Anticipated Study Completion Date :

Aug 1, 2023

Arms and Interventions

Arm	Intervention/Treatment
Placebo Comparator: Control Post-test satisfaction	Behavioral: Telephone Follow-up Telephone Follow-up within 72 hours to discuss psycho education, discharge planning and clarify any questions they may have.
Experimental: Experimental Treatment and satisfaction	Behavioral: Telephone Follow-up Telephone Follow-up within 72 hours to discuss psycho education, discharge planning and clarify any questions they may have.

Arm

Intervention/Treatment

Placebo Comparator: Control

Post-test satisfaction

Behavioral: Telephone Follow-up

Telephone Follow-up within 72 hours to discuss psycho education, discharge planning and clarify any questions they may have.

Experimental: Experimental

Treatment and satisfaction

Behavioral: Telephone Follow-up

Telephone Follow-up within 72 hours to discuss psycho education, discharge planning and clarify any questions they may have.

Outcome Measures

Primary Outcome Measures

Emergency Department readmission rates [30 days.]
Does a telephone call reduce readmission rates?

Secondary Outcome Measures

Satisfaction with care in the Emergency Department using a 7 point Likert Scale as a function of the telephone follow up. [30 days.]
Various measures of satisfaction in care provided in Emergency Department. Higher scores indicate higher satisfaction.
Adherence to pharmacological interventions and follow-up appointments. [30 days.]
Adhering to pharmacological interventions and follow-up appointments by self rating on a 7 point Likert Scale. Higher scores indicate greater adherence to treatment adherence.
Understanding of Treatment plan [30 days.]
Assessing if the participant believes they have a good understanding of their care plan by self rating on a 7 point Likert Scale. Higher scores indicate greater understanding of treatment plan.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria

Discharged from the ED
Age of majority
Competent.

Exclusion Criteria

Incompetent,
Under 18
Admitted to the hospital

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	St. Boniface Hospital	Winnipeg	Manitoba	Canada	R2H 2A6

Sponsors and Collaborators

Brandon University

Investigators

Principal Investigator: Alana E Prejet, BScPN, BA, Brandon University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Alana Prejet, Principal Investigator, Brandon University

ClinicalTrials.gov Identifier:

NCT04793282

Other Study ID Numbers:

BrandonU

First Posted:

Mar 11, 2021

Last Update Posted:

Aug 8, 2022

Last Verified:

Aug 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Alana Prejet, Principal Investigator, Brandon University

Telephone follow up

Study Results

No Results Posted as of Aug 8, 2022